OF ALL the goods and services traded in the market economy, pharmaceuticals are perhaps the most contentious. Though produced...
Archive for category: Intellectual Property Rights
The Trans-Pacific Partnership And The Costs of Drug Patent Monopolies – Courtesy(OurFuture.org)
Pharma Live, , Intellectual Property Rights, 0The debate over the Trans-Pacific Partnership (TPP) has taken center stage in policy circles in recent weeks. Its proponents...
FDA Announces Major Proposed Rule Amending Hatch-Waxman Regulations – Courtesy (Hogan Lovells)
Pharma Live, , Intellectual Property Rights, 0On February 6, 2015, the Food and Drug Administration (FDA) published in the Federal Register (FR) a comprehensive proposed...
No paediatric extension when conditions are not met before SPC expires – Courtesy ( The SPC Blog)
Pharma Live, , Intellectual Property Rights, 0Otsuka Pharmaceuticals Company Limited’s application, 4 March 2015, Dr Lawrence Cullen, for the United Kingdom’s Intellectual Property Office (UKIPO), held...
Telmisartan: no double-dipping says CJEU, as it avoids answering all the questions – Courtesy (The SPC Blog)
Pharma Live, , Intellectual Property Rights, 0The Court of Justice of the European Union (CJEU) delivered its ruling in Case C‑577/13, Actavis Group PTC EHF, Actavis UK...
Prepare for the Japanese Patent Opposition System Coming Soon – Courtesy (Global IP Matters)
Pharma Live, , Intellectual Property Rights, 0The Japanese Patent Act was revised on May 14, 2014 to provide for post-grant oppositions within one year of the rule...
Maximizing Use of the USPTO’s Patent Application Alert Service
Pharma Live, , Intellectual Property Rights, 0The U.S. Patent and Trademark Office (USPTO) recently launched the Patent Application Alert Service (PAAS), a free electronic tool aimed to...
Helping U.S. Patent Applicants Get Speedy Examination – Courtesy (Global IP Matters)
Pharma Live, , Intellectual Property Rights, 0U.S. patent applicants often have an interest in expediting the patent examination process. The desire to speed examination can...
RCEs and the New USPTO Patent Term Adjustment Rules – Courtesy (Global IP Matters)
Pharma Live, , Intellectual Property Rights, 0On January 9, 2015, the Federal Register published final rules implementing changes to patent term adjustment (PTA) in view of Novartis v....
Court Denies Generic Drug Manufacturer’s Motion to Dismiss Hatch-Waxman Patent Infringement Action on Jurisdiction Grounds
Pharma Live, , Intellectual Property Rights, 0the United States District Court for the Southern District of Indiana joined the District of Delaware and Eastern District...